Preliminary Pharmacologic Selection Framework for COVID-19 Delirium

Faced with no guidelines for treating delirium in COVID-19 patients, colleagues in the Department of Psychiatry at Massachusetts General Hospital set out to provide pharmacologic recommendations—based on the experiences of C-L psychiatrists managing patients with the virus.

Read more:

Return to news archive